Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

The woman was misdiagnosed with Graves Disease, leading to incorrect treatment, while she actually had Pituitary Resistance to Thyroid Hormone.

Adolescents with PCOS have higher levels of certain androgens, which are linked to hair growth but don't help diagnose PCOS better than testosterone levels.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Serum steroid profiling, especially 11-deoxycortisol, helps distinguish between adrenocortical carcinoma and adenoma, considering sex and functional status.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

Menopause-related skin changes may increase fungal infections and inflammation.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

COVID-19 severely affects older adults with chronic heart, lung, or metabolic diseases.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

New treatments for male hypogonadism are effective and should be personalized.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Higher variability in systolic blood pressure increases long-term mortality risk in coronary artery disease patients.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

The study suggests pandemic stress might worsen or trigger hair loss problems.